ClinicalTrials.Veeva

Menu

Transcranial Direct Current Stimulation of the Primary Motor Cortex to Treat Levodopa-induced Dyskinesias

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Parkinson Disease

Treatments

Device: Transcranial direct current stimulation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The main objective of the study is to evaluate the efficacy of 10 sessions of transcranial direct current stimulation of the primary motor cortex to reduce levodopa-induced dyskinesia

Enrollment

32 estimated patients

Sex

All

Ages

30 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with diagnosis of idiopathic Parkinson's disease according to Movement Disorder Society (MDS) criteria and levodopa-induced dyskinesia;
  • age between 30 and 80 years;
  • ongoing therapy with levodopa;
  • fulfillment of requirements for the application of transcranial magnetic stimulation (TMS), assessed by completion of the TMS screening questionnaire.

Exclusion criteria

  • patients unable to give informed consent;
  • cognitive impairment (MMSE ≤ 24);
  • history of epilepsy;
  • pregnant women.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

32 participants in 2 patient groups

Active stimulation
Experimental group
Description:
Ten sessions of cathodic transcranial direct current stimulation over primary motor cortex
Treatment:
Device: Transcranial direct current stimulation
Sham stimulation
Sham Comparator group
Description:
Ten sessions of sham stimulation over primary motor cortex
Treatment:
Device: Transcranial direct current stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Francesco Bove, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems